The session highlights the transformative impact of the cell and gene therapy revolution on the modern medicine landscape. Emphasizing the critical role of quality assurance, the session navigates through unique quality and compliance challenges associated with advanced therapies. Strategies for efficient scaling and market entry during the clinical to commercial transition are explored, with a focus on ensuring uninterrupted access to advanced therapies and examining supply chain resilience. The discussion extends to the crucial aspect of ensuring safety and efficacy as therapies reach wider populations, leveraging real-time monitoring and agile adjustments. Real-world case studies are showcased to illustrate successful clinical to commercial transitions and their far-reaching impact. In this session, you will:

• Find out more about the transformative impact of the cell and gene therapy revolution in modern medicine
• Understand the unique quality and compliance challenges in advanced therapies
• Learn more about best strategies for successful clinical to commercial transitions and ensuring safety and efficacy in wider populations.